Pacerone review

Pacerone, a prescription medication that alters the hearts rhythm, is defined as an antiarrhythmic medication and is commonly given to patients suffering from heart rhythm disorders which can be life threatening when not addressed. Other brand names commonly attributed to Pacerone include Cordarone, and Cordarone I.V. This medication was discovered in 1961 but was only cleared for use in the United States by the Food and Drug Administration in 1985. Pacerone is used to treat ventricular fibrillation or ventricular tachycardia, which are rhythm disorders of the ventricle found in the lower portion of the heart in charge of moving blood out of the organ.

Pacerone is only given in life-threatening situations due to potentially fatal side effects and severe allergic reactions. Patients that are allergic to iodine or Pacerone should not take this medication. Patients suffering from heart conditions should consult a physician before taking this medication. It is typically used for patients suffering from serious irregular heartbeats of the heart; which include atrial flutter, atrial fibrillation, ventricular tachycardia, and ventricular fibrillation.

Patients must undergo an extensive physical and medical examination by a physician prior to taking Pacerone. Dosage depends on certain factors and requires that you tell your physician about the current condition of your body to avoid fatal side effects.

Pacerone is administered in the hospital where your condition is carefully monitored to detect and immediately address any side effects that could be fatal. Avoid self-medication. This medication should be taken with a full glass of water to properly dilute.

A person taking Pacerone should seek immediate medical attention in the event any of the following allergic reactions occur: breathing problems, skin edema of the face, lips, throat, or tongue and hives.

Common side effects include fast and slow pounding heartbeats, irregular heartbeat pattern, dizziness and fainting, chest pains, flu-like symptoms, blurring of vision, short breathing, weight-loss, sudden body temperature change, increased perspiration, numbness, burning sensation, nausea, vomiting, stomach pain, fever, clay-colored stools, and jaundice. The above-mentioned symptoms might occur during the treatment or up to a few months after taking the medication. It is very important to consult a physician if any of these conditions appear to avoid fatal or life-threatening conditions.

Pacerone reacts to other medications containing cytochrome P450 isozyme. These include cyclosporine, flecainide, quinidine, simvastatin, warafin, and other medications under the same family. The dose of these medications should be halved to avoid complications. If you are taking any of these medications, make certain your physician is aware.

Patients suffering from lung disorder (asthma), vision problems, thyroid disorder, liver illness, blood pressure problems, electrolyte imbalance, or heart attachments may require a dose adjustment. Consult your physician and make certain they are aware of your medical history.

This medication is in Category D Pregnancy. Women who are pregnant or may become pregnant are advised not to take Pacerone since it might harm the fetus. Inform your physician if you become pregnant during treatment to avoid problems. Lactating mothers are advised to avoid breastfeeding since Pacerone can be easily passed into breast milk and cause harm to the nursing baby.

Pacerone has the following structural formula:

Chemical structure of pacerone

• Molecular formula of pacerone is C25H29I2NO3
• Chemical IUPAC Name is (2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone
• Molecular weight is 645.312 g/mol
Pacerone available : 200mg tablets

Generic name: Amiodarone

Brand name(s): Amiodarona, Amiodarons, Amjodaronum, Cordarone, Labaz

  Your Pacerone review